Standard BioTools (NASDAQ: LAB) has announced that it will be unveiling its third quarter financial results on Wednesday 30th October 2024. This announcement is set to occur after market close, allowing investors and analysts to gain valuable insights into the company's performance during the quarter.
Financial analysts on Wall Street are predicting that the establishment is about to reveal an estimated $0.09 loss per share for the quarter. Additionally, the company is projected to announce a total revenue of $41 million for this period.
The projections from Wall Street analysts indicate that the company is expected to generate a total revenue of $171.19 million for the full year. Moreover, they anticipate the earnings per share to reach loss of $0.46 during the fiscal year.
In the previous year's corresponding quarter, the company's earnings report revealed a per-share loss of $0.27. Moreover, the company achieved a remarkable total revenue of $25.37 million during that quarter.
LAB will host a conference call with investment community on 30th October 2024 at 04:30 PM eastern time to discuss the financial results.
Standard BioTools (LAB) closed Monday's regular trading session at $1.70, marking a 1.19 percent rise. The stock fluctuated between $1.67 and $1.76 during the day, with a volume of 2.59 million shares.